Next-Generation Sequencing Market - Global Forecasts to 2021.pdf

  • View
    568

  • Download
    0

Embed Size (px)

Transcript

  • 1sales@marketsandmarkets.com www.marketsandmarkets.com

    NEXT-GENERATION SEQUENCING(NGS) MARKET

    GLOBAL FORECASTS TO 2021

    NEXT-GENERATION SEQUENCING (NGS) MARKET - GLOBAL FORECASTS TO 2021 By Platforms (HISEQ, MISEQ, HISEQ X Ten/X Five, Nextseq500, Ion Proton, PGM, IONS5, Pacbio & Sequel), Services (Targeted Sequencing, De Novo), & Application (Diagnostic, Drug Discovery)

    REPORT OVERVIEW

    1.1 OBJECTIVES OF THE STUDY

    To define, describe, and forecast the next-generation sequencing (NGS) market on the basis of products & services, technologies, applications, end users, and regions

    To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges) along with the current trends

    To strategically analyze micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market

    To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

    To forecast the revenue of the market segments with respect to four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World

    To strategically profile the key players and comprehensively analyze their market shares and core competencies

    To track and analyze competitive developments such as new product launches; agreements, partnerships, and collaborations; mergers & acquisitions; and research & development activities in the NGS market

    HEALTHCARE

    REPORT CODEBT 2697

  • 2sales@marketsandmarkets.com www.marketsandmarkets.com

    1.2 MARKET DEFINITION

    Next-generation sequencing refers to non-Sanger-based high-throughput DNA sequencing technologies. Millions or billions of DNA strands can be sequenced in parallel, yielding substantially more throughput and minimizing the need for the fragment-cloning methods that are often used in Sanger sequencing of genomes. The ability to sequence DNA opened up abundant application avenues for NGS technologies in scientific research including personalized medicine, cancer, drug discovery, and agricultural & animal sciences.

    1.3 MARKET SCOPE

    The market study covers pre-sequencing products & services, NGS platforms, sequencing services, and data analysis tools to arrive at the NGS product and services market size for the period of 2016 to 2021

    The market study covers the market size of the NGS technologies. Detailed market scope of each type of NGS technology has been provided in chapter 7 (NGS market, by technology)

    The NGS market, by application, includes the market size of NGS products and services used for various applications

    1.3.1 MARKETS COVERED

    This research report categorizes the NGS market into the following segments:

    GLOBAL NEXT-GENERATION SEQUENCING MARKET (NGS), BY PRODUCTS AND SERVICES

    Pre-sequencing Products and Services

    DNA Fragmentation and Size Selection

    Library Preparation & Target Enrichment

    Quality Control

    NGS Platforms, Consumables/Reagents, and Services

    Illumina

    HiSeq Series

    HiSeq X Ten & HiSeq X Five

    MiSeq Series

    NextSeq 500

    Life Technologies (Thermo Fisher)

    SOLiD Series

    Ion PGM (Personal Genome Machine)

    Ion Proton

    Ion S5 & Ion S5 XL

    Pacific Biosciences

    PacBio RS II

    Sequel System

    INTRODUCTION

  • 3sales@marketsandmarkets.com www.marketsandmarkets.com

    Other Platforms

    Sequencing Services

    NGS Data Analysis/Bioinformatics

    By Product

    NGS Data Analysis Software and Workbenches

    NGS Data Analysis Services

    NGS Storage Management and Cloud Computing Solutions

    By Application

    Whole-genome Sequencing

    Exome Sequencing

    Targeted Resequencing

    De Novo Sequencing

    RNA Sequencing

    ChIP Sequencing

    Methyl Sequencing

    Others

    GLOBAL NGS MARKET, BY TECHNOLOGY

    Sequencing by Synthesis (SBS)

    Ion Semiconductor Sequencing

    Sequencing by Ligation (SBL)

    Pyrosequencing

    Single-Molecule Real-time (SMRT) Sequencing

    Other Technologies

    GLOBAL NGS MARKET, BY APPLICATION

    Diagnostics

    Drug Discovery

    Biomarker Discovery

    Personalized Medicine

    Agriculture and Animal Research

    Others

    INTRODUCTION

  • 4sales@marketsandmarkets.com www.marketsandmarkets.com

    GLOBAL NGS MARKET, BY END USER

    Research Centers & Academic/Government Institutes

    Hospitals & Clinics

    Pharmaceutical & Biotechnology Companies

    Others

    GLOBAL NGS MARKET, BY REGION

    North America

    Europe

    Asia-Pacific

    Rest of the World

    1.3.2 YEARS CONSIDERED FOR THE STUDY

    1.4 CURRENCY

    The currency used in the report is USD, with market size indicated in USD million.

    For companies reporting their revenues in USD, the revenues were picked from their annual reports

    For companies that reported their revenues in other currencies, the average annual currency conversion rate was used for the particular year to convert the value to USD

    INTRODUCTION

  • 5sales@marketsandmarkets.com www.marketsandmarkets.com

    1.5 LIMITATIONS

    Following limitations were faced during the research study on the NGS market:

    However, to overcome the limitations and to maintain the effectiveness of the research work, several strategic approaches and recommendations of the industry experts were utilized to come up with the research study.

    1.6 STAKEHOLDERS

    NGS Equipment Manufacturers, Vendors, and Distributors

    NGS Sequencing Services Companies

    NGS Bioinformatics/Data Analysis Companies

    Research Institutes and Government Organizations

    Venture Capitalists and Other Government Funding Organizations

    Research and Consulting Firms

    Healthcare Institutions (Hospitals and Medical Schools)

    Pharmaceutical and Biotechnology Companies

    Contract Manufacturing Organizations (CMOs)

    Contract Research Organizations (CROs)

    INTRODUCTION

  • 6sales@marketsandmarkets.com www.marketsandmarkets.com

    2.1 RESEARCH DATA

    This research study involved the usage of extensive secondary sources; directories; and databases such as Hoovers, Bloomberg Business, Factiva, and Avention; along with government databases, to identify and collect information useful for this technology-based, market-oriented, and commercial study of the NGS market. In-depth interviews were conducted from various primary respondents that mainly include key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure shows the market research methodology applied in making this report on the NGS market.

    FIGURE 1 RESEARCH DESIGN

    2.1.1 SECONDARY DATA

    The secondary sources referred to for this research study include publications from government sources [such as the National Institutes of Health (NIH), U.S. FDA, World Bank, and Intellectual Property Office (U.K.)]; corporate filings (such as annual reports, SEC filings, investor presentations, and financial statements); research journals; press releases; and trade, business, and professional associations; among others.

    RESEARCH METHODOLOGY

  • 7sales@marketsandmarkets.com www.marketsandmarkets.com

    Secondary research was mainly used to obtain key information about the industrys total pool of key players, market classification and segmentation according to industry trends to the bottom-most segment level, global market trends, and key developments by both public and private organizations in the NGS market.

    2.1.1.1 KEY DATA FROM SECONDARY SOURCES

    2.1.2 PRIMARY DATA

    Extensive primary research was conducted after acquiring knowledge about the NGS market scenario through secondary research. More than 40 primary interviews were conducted from both the demand (sequencing services companies, cancer research laboratories, hospitals, research universities, and government laboratories) and supply sides (NGS platform manufacturers and distributors). The primaries interviewed for this study include experts from the NGS industry, such as CEOs, VPs, directors, sales heads, and marketing managers of tier 1, 2, and 3 companies engaged in offering NGS products and services across the globe; administrators and purchase managers of NGS products; and academic research institutes. Approximately 62% and 38% primary interviews were conducted from both the demand and supply sides, respectively. This primary data was collected through questionnaires, mails, and telephonic interviews.

    RESEARCH METHODOLOGY

  • 8sales@marketsandmarkets.com www.marketsandmarkets.com

    2.1.2.1 BREAKDOWN OF PRIMARIES

    FIGURE 2 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

    AND REGION

    31.4%

    48.6%

    20.0%

    BY COMPANIES

    Tier 1 Tier 2 Tier 3

    27.8%

    19.4%

    52.8%

    BY DESIGNATION

    C Level Director Level Other

    30.6%

    33.3%

    19.4%

    16.7%

    BY REGION

    North America Europe

    Asia-Pacific RoW

    Note 1: *Others include sales managers, marketing managers, and product managers.

    2: Companies are classified into tiers based on their total revenue, as of 2015: Tier 1 = >USD 500 million, Tier 2 = USD 500 million to USD 100 million, and Tier 3 =

  • 9sales@marketsandmarkets.com www.ma